Kurm Pharma ApS Financials, key figures and credit report
Gross profit -2 598.2 kDKK FY 2025 -884.6% vs 2024
EBIT -2 598.2 kDKK FY 2025 -1,030.8% vs 2024
Net debt 2 236.5 kDKK FY 2025 +27.7% vs 2024
Quick ratio 1.6 FY 2025 -0.9 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 2 610.38 | 459.14 | 91.00 | 331.13 | -2 598.15 |
| Total depreciation | -48.00 | -48.00 | -48.00 | -52.00 | |
| EBIT | 2 562.38 | 411.14 | 43.00 | 279.13 | -2 598.15 |
| Other financial income | 7.27 | 43.54 | 268.30 | 495.94 | 75.27 |
| Other financial expenses | -8.76 | -22.40 | -1.22 | -1.64 | -13.81 |
| Pre-tax profit | 2 560.89 | 432.27 | 310.08 | 773.44 | -2 536.69 |
| Income taxes | - 564.74 | -99.75 | -68.35 | - 171.25 | 558.04 |
| Net earnings | 1 996.15 | 332.53 | 241.73 | 602.19 | -1 978.65 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Goodwill | 148.00 | 100.00 | 52.00 | ||
| Intangible assets total | 148.00 | 100.00 | 52.00 | ||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 2 745.28 | 2 413.62 | 4 133.73 | 6 401.77 | 4 247.42 |
| Current amounts owed by group member comp. | 26.58 | ||||
| Current other receivables | 1 837.94 | 1 030.30 | 101.89 | 102.61 | 265.69 |
| Current deferred tax assets | 55.07 | 558.04 | |||
| Short term receivables total | 4 583.21 | 3 443.92 | 4 290.69 | 6 530.96 | 5 071.16 |
| Cash and bank deposits | 118.60 | 152.99 | 498.04 | 339.52 | 31.60 |
| Cash and cash equivalents | 118.60 | 152.99 | 498.04 | 339.52 | 31.60 |
| Balance sheet total (assets) | 4 849.82 | 3 696.92 | 4 840.73 | 6 870.48 | 5 102.76 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Shares repurchased | 190.00 | 300.00 | |||
| Retained earnings | 869.08 | 2 865.24 | 3 197.76 | 3 139.49 | 3 741.68 |
| Profit of the financial year | 1 996.15 | 332.53 | 241.73 | 602.19 | -1 978.65 |
| Shareholders equity total | 3 105.24 | 3 247.76 | 3 489.49 | 4 091.68 | 1 813.03 |
| Non-current liabilities total | |||||
| Current trade creditors | 234.68 | 421.41 | 153.33 | 517.07 | 1 021.57 |
| Current owed to group member | 1 149.49 | 2 090.48 | 2 268.15 | ||
| Short-term deferred tax liabilities | 504.74 | 27.75 | 48.42 | 171.25 | |
| Other non-interest bearing current liabilities | 1 005.16 | ||||
| Current liabilities total | 1 744.58 | 449.16 | 1 351.24 | 2 778.80 | 3 289.73 |
| Balance sheet total (liabilities) | 4 849.82 | 3 696.92 | 4 840.73 | 6 870.48 | 5 102.76 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated